82 related articles for article (PubMed ID: 8510231)
21. Differential regulation of the human immunodeficiency virus type 2 enhancer in monocytes at various stages of differentiation.
Hilfinger JM; Clark N; Smith M; Robinson K; Markovitz DM
J Virol; 1993 Jul; 67(7):4448-53. PubMed ID: 8510231
[TBL] [Abstract][Full Text] [Related]
22. Activation of the human T-cell leukemia virus type I enhancer is mediated by binding sites for Elf-1 and the pets factor.
Clark NM; Smith MJ; Hilfinger JM; Markovitz DM
J Virol; 1993 Sep; 67(9):5522-8. PubMed ID: 8350410
[TBL] [Abstract][Full Text] [Related]
23. The peri-kappa B site mediates human immunodeficiency virus type 2 enhancer activation in monocytes but not in T cells.
Clark NM; Hannibal MC; Markovitz DM
J Virol; 1995 Aug; 69(8):4854-62. PubMed ID: 7609053
[TBL] [Abstract][Full Text] [Related]
24. Activation of the human immunodeficiency virus type 2 enhancer is dependent on purine box and kappa B regulatory elements.
Markovitz DM; Smith MJ; Hilfinger J; Hannibal MC; Petryniak B; Nabel GJ
J Virol; 1992 Sep; 66(9):5479-84. PubMed ID: 1501284
[TBL] [Abstract][Full Text] [Related]
25. Purification of the pets factor. A nuclear protein that binds to the inducible TG-rich element of the human immunodeficiency virus type 2 enhancer.
Fu GK; Markovitz DM
J Biol Chem; 1996 Aug; 271(32):19599-605. PubMed ID: 8702655
[TBL] [Abstract][Full Text] [Related]
26. Synergistic interactions between overlapping binding sites for the serum response factor and ELK-1 proteins mediate both basal enhancement and phorbol ester responsiveness of primate cytomegalovirus major immediate-early promoters in monocyte and T-lymphocyte cell types.
Chan YJ; Chiou CJ; Huang Q; Hayward GS
J Virol; 1996 Dec; 70(12):8590-605. PubMed ID: 8970984
[TBL] [Abstract][Full Text] [Related]
27. Infection with the human immunodeficiency virus type 2.
Markovitz DM
Ann Intern Med; 1993 Feb; 118(3):211-8. PubMed ID: 8380244
[TBL] [Abstract][Full Text] [Related]
28. Establishment and characterization of a human acute monocytic leukemia cell line (THP-1).
Tsuchiya S; Yamabe M; Yamaguchi Y; Kobayashi Y; Konno T; Tada K
Int J Cancer; 1980 Aug; 26(2):171-6. PubMed ID: 6970727
[TBL] [Abstract][Full Text] [Related]
29. An undifferentiated variant derived from the human acute myelogenous leukemia cell line (KG-1).
Koeffler HP; Billing R; Lusis AJ; Sparkes R; Golde DW
Blood; 1980 Aug; 56(2):265-73. PubMed ID: 6967340
[TBL] [Abstract][Full Text] [Related]
30. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.
Gorman CM; Moffat LF; Howard BH
Mol Cell Biol; 1982 Sep; 2(9):1044-51. PubMed ID: 6960240
[TBL] [Abstract][Full Text] [Related]
31. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.
Dignam JD; Lebovitz RM; Roeder RG
Nucleic Acids Res; 1983 Mar; 11(5):1475-89. PubMed ID: 6828386
[TBL] [Abstract][Full Text] [Related]
32. Immunoglobulin gene transcription is activated by downstream sequence elements.
Queen C; Baltimore D
Cell; 1983 Jul; 33(3):741-8. PubMed ID: 6409419
[TBL] [Abstract][Full Text] [Related]
33. Human leukemic models of myelomonocytic development: a review of the HL-60 and U937 cell lines.
Harris P; Ralph P
J Leukoc Biol; 1985 Apr; 37(4):407-22. PubMed ID: 3855947
[TBL] [Abstract][Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]